...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: And we wait.....
Reply New Message
Prev Message Back To Forum Threaded View Next Message

....Why are we still waiting on the 10 MM share private placement that has been advertised by Zenith since October 2017 as coming soon?....

The November presentation says....

Enterprise
Value est.
$350 to $375MM USD
($3.00 USD/Share) est.

The December and January presentations say.....

Enterprise
Value est.
$350 to $375MM USD
($2.50 to $3.00 USD/share) est.

What's the reason for the share-price-estimate drop to a range?  Perhaps it reflects some difficulty getting a higher, hoped-for private-placement share price, and/or ongoing negotiations, therefore delays?

6 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply